A.forall expands US generics portfolio
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach ANDERLECHT, BRUSSELS, BELGIUM, September 9, 2025 /EINPresswire.com/ -- A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and …